Clinical trial
Study Evaluating InductOs in Diaphyseal Tibia Fractures
NCT00161616 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00161616 |
|---|---|
| Title | Study Evaluating InductOs in Diaphyseal Tibia Fractures |
| Official title | A Prospective, Randomized, Controlled, Stratified Study of InductOs in Subjects With Open Diaphyseal Tibia Fractures Treated With Reamed Locked Intramedullary Nail Fixation |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Tibial Fractures |
| Intervention type | Drug |
| Interventions | InductOs |
| Enrollment | 277 |
| Start date | Sep 1, 2003 |
| Primary completion | Jul 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 7, 2009 |
| Countries | Belgium, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Romania, South Africa, Spain, United Kingdom |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: